Empresa Pharmala Biotech Holdings Inc.
Acciones
MDMA
CA71719L1067
Biotecnología e investigación médica
Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
0,21 CAD | -.--% | -.--% | +50,00 % |
Resumen de negocios
Ventas por actividad
CAD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Engineering-grade (Non-GMP) Product
100,0
%
| 0 | 100,0 % | 1 | 100,0 % | +581,44 % |
Ventas por región
CAD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Canada
100,0
%
| 0 | 100,0 % | 1 | 100,0 % | +581,44 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Nick Kadysh
CEO | Chief Executive Officer | 38 | 21/03/21 |
Carmelo Marrelli
DFI | Director of Finance/CFO | 53 | 22/03/21 |
Harpreet Kaur
CTO | Chief Tech/Sci/R&D Officer | - | - |
Shane Morris
COO | Chief Operating Officer | 49 | 22/03/21 |
David Purcell
SAM | Sales & Marketing | - | 14/03/22 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Kevin Roy
BRD | Director/Board Member | - | 04/06/22 |
Director/Board Member | 62 | 21/03/21 | |
Jodi Butts
CHM | Chairman | 51 | 21/03/21 |
Nick Kadysh
CEO | Chief Executive Officer | 38 | 21/03/21 |
Perry Tsergas
BRD | Director/Board Member | 39 | 21/03/21 |
Fraser MacDonald
BRD | Director/Board Member | 38 | 21/03/21 |
Harriet de Wit
BRD | Director/Board Member | 76 | 21/03/21 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 86 907 552 | 81 657 052 ( 93,96 %) | 0 | 93,96 % |
Información de la empresa
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+50,00 % | 13,28 M | |
-3,46 % | 102 mil M | |
+1,41 % | 96,09 mil M | |
+2,13 % | 22,28 mil M | |
-15,84 % | 21,4 mil M | |
-9,21 % | 18,14 mil M | |
-39,98 % | 17,02 mil M | |
-14,65 % | 16,09 mil M | |
+4,39 % | 13,83 mil M | |
+31,35 % | 11,97 mil M |
- Bolsa de valores
- Acciones
- Acción MDMA
- Empresa Pharmala Biotech Holdings Inc.